ロード中...
Androgen Receptor Rearrangement and Splicing Variants in Resistance to Endocrine Therapies in Prostate Cancer
In the last few years, the survival of patients with castration-resistant prostate cancer (CRPC) has significantly improved as a result of the development of second-generation androgen deprivation therapies such as abiraterone and second-generation antagonists such as enzalutamide. However, CRPC pat...
保存先:
| 出版年: | Endocrinology |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Endocrine Society
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5460940/ https://ncbi.nlm.nih.gov/pubmed/28368512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2017-00109 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|